Bonus Biogroup (Israel) Today
| BONS Stock | ILS 16.30 0.40 2.40% |
Performance0 of 100
| Odds Of DistressLess than 24
|
Bonus Biogroup is trading at 16.30 as of the 24th of April 2024, a -2.4% down since the beginning of the trading day. The stock's open price was 16.7. Bonus Biogroup has about a 24 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for Bonus Biogroup are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of March 2024 and ending today, the 24th of April 2024. Click here to learn more.
Bonus BioGroup Ltd., a biotechnology company, develops technology solutions to generate tissue-regenerating bone grafts. Bonus BioGroup Ltd., formerly known as Oceana Advanced Industries Ltd., was founded in 1981 and is based in Haifa, Israel. BONUS BIOGROUP is traded on Tel Aviv Stock Exchange in Israel.. The company has 1.17 B outstanding shares. More on Bonus Biogroup
Moving against Bonus Stock
| 0.45 | APLY | Aerodrome Group | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Bonus Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Bonus Biogroup's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Bonus Biogroup or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Shai Meretzki |
| Business Concentration | Health Care, Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care (View all Sectors) |
Bonus Biogroup (BONS) is traded on Tel Aviv Stock Exchange in Israel and employs 13 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 223.15 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bonus Biogroup's market, we take the total number of its shares issued and multiply it by Bonus Biogroup's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Bonus Biogroup operates under Biotechnology sector and is part of Health Care industry. The entity has 1.17 B outstanding shares.
Bonus Biogroup has accumulated about 3.6 M in cash with (39.84 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Check Bonus Biogroup Probability Of Bankruptcy
Ownership AllocationBonus Biogroup retains a total of 1.17 Billion outstanding shares. Bonus Biogroup retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Bonus Ownership Details
Bonus Stock Price Odds Analysis
What are Bonus Biogroup's target price odds to finish over the current price? Depending on a normal probability distribution, the odds of Bonus Biogroup jumping above the current price in 90 days from now is more than 93.0%. The Bonus Biogroup probability density function shows the probability of Bonus Biogroup stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon Bonus Biogroup has a beta of 0.6785 suggesting as returns on the market go up, Bonus Biogroup average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Bonus Biogroup will be expected to be much smaller as well. Additionally, bonus Biogroup has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Bonus Biogroup to move above the current price in 90 days from now is more than 93.0 (This Bonus Biogroup probability density function shows the probability of Bonus Stock to fall within a particular range of prices over 90 days) .
Bonus Biogroup Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Bonus Biogroup market risk premium is the additional return an investor will receive from holding Bonus Biogroup long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Bonus Biogroup. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Bonus Biogroup's alpha and beta are two of the key measurements used to evaluate Bonus Biogroup's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 4.21 | |||
| Standard Deviation | 6.1 | |||
| Variance | 37.19 | |||
| Risk Adjusted Performance | 0.0011 |
Bonus Stock Against Markets
Picking the right benchmark for Bonus Biogroup stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Bonus Biogroup stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Bonus Biogroup is critical whether you are bullish or bearish towards Bonus Biogroup at a given time. Please also check how Bonus Biogroup's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Bonus Biogroup without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Diagnostics Now
Portfolio DiagnosticsUse generated alerts and portfolio events aggregator to diagnose current holdings |
| All Next | Launch Module |
Bonus Biogroup Corporate Directors
Bonus Biogroup corporate directors refer to members of a Bonus Biogroup board of directors. The board of directors generally takes responsibility for the Bonus Biogroup's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Bonus Biogroup's board members must vote for the resolution. The Bonus Biogroup board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Gil Shapira | Director | Profile | |
| Daniel BenLulu | Director | Profile | |
| Avi Slonim | External Director | Profile | |
| Yehuda Reznik | Director | Profile |
How to buy Bonus Stock?
Before investing in Bonus Biogroup, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Bonus Biogroup. To buy Bonus Biogroup stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Bonus Biogroup. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Bonus Biogroup stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Bonus Biogroup stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Bonus Biogroup stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Bonus Biogroup, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Bonus Biogroup?
The danger of trading Bonus Biogroup is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Bonus Biogroup is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Bonus Biogroup. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Bonus Biogroup is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bonus Biogroup. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Bonus Stock analysis
When running Bonus Biogroup's price analysis, check to measure Bonus Biogroup's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bonus Biogroup is operating at the current time. Most of Bonus Biogroup's value examination focuses on studying past and present price action to predict the probability of Bonus Biogroup's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bonus Biogroup's price. Additionally, you may evaluate how the addition of Bonus Biogroup to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |